Vivos Therapeutics, Inc. ( NASDAQ: VVOS) Q3 2024 Earnings Conference Call November 14, 2024 5:00 PM ET Kirk Huntsman - Chariman & CEO Brad Amman - CFO Scott Henry - Alliance Global Partners Lucas Ward ...
Industry-Best Total Mobile and Fixed customer growth of 347,000 driven by strong demand for our leading portfolio of services across Mobility and Fixed Strong Mobile Phone and Connected Device net ...